New Nonextractive and Highly Sensitive High-Performance Liquid Chromatographic Method for Determination of Paroxetine in Plasma After Offline Precolumn Derivatization with 7-Chloro-4-Nitrobenzo-2-Oxa-1,3-DiazoleDARWISH, Ibrahim A; AL-MAJED, Abdulrahman A; MAHMOUD, Ashraf M et al.Journal of AOAC International. 2009, Vol 92, Num 5, pp 1349-1355, issn 1060-3271, 7 p.Article

Nitric oxide is involved in the regulation of marble-burying behaviorKRASS, Maarja; RÜNKORG, Kertu; WEGENER, Gregers et al.Neuroscience letters. 2010, Vol 480, Num 1, pp 55-58, issn 0304-3940, 4 p.Article

Resolution of Brugada-pattern ECG after withdrawal of the selective serotonin reuptake inhibitor paroxetineSAWHNEY, V; THOMAS, G; WEBSTER, P et al.Heart (London 1996). 2010, Vol 96, Num 14, pp 1165-1166, issn 1355-6037, 2 p.Article

Granuloma annulare photoinduced by paroxetineALVAREZ-PEREZ, Adriana; GOMEZ-BERNAL, Silvia; GUTIERREZ-GONZALEZ, Enrique et al.Photodermatology photoimmunology & photomedicine. 2012, Vol 28, Num 1, pp 47-49, issn 0905-4383, 3 p.Article

Accommodation to serotonin reuptake inhibitor-induced sexual dysfunctionASHTON, A. K; ROSEN, R. C.Journal of sex and marital therapy. 1998, Vol 24, Num 3, pp 191-192, issn 0092-623XArticle

Serotonin transporter mRNA expression in peripheral leukocytes of patients with major depression before and after treatment with paroxetineIGA, Jun-Ichi; UENO, Shu-Ichi; YAMAUCHI, Ken et al.Neuroscience letters. 2005, Vol 389, Num 1, pp 12-16, issn 0304-3940, 5 p.Article

Perinatal outcome following third-trimester exposure to paroxetine: An alternative interpretationPRYSE-PHILLIPS, William; YUEN, Doris E.Archives of pediatrics & adolescent medicine. 2003, Vol 157, Num 6, issn 1072-4710, p. 601Article

Aggressive behaviour and platelet ³H-paroxetine binding in schizophreniaMAGUIRE, K; CHEUNG, P; CROWLEY, K et al.Schizophrenia research. 1997, Vol 23, Num 1, pp 61-67, issn 0920-9964Article

TREACHER COLLINS SYNDROME WITH MULTIPLE CONGENITAL HEART DEFECTS AFTER PAROXETINE EXPOSURE: CASE REPORTDINLEN, N; ZENCIROGLU, A; DILLI, D et al.Genetic counseling. 2014, Vol 25, Num 1, pp 7-11, issn 1015-8146, 5 p.Article

Pharmacokinetic model incorporating mechanism-based inactivation of CYP2D6 can explain both non-linear kinetics and drug interactions of paroxetineMIKAMI, Akiko; OHTANI, Hisakazu; HORI, Satoko et al.International journal of clinical pharmacology and therapeutics. 2013, Vol 51, Num 5, pp 374-382, issn 0946-1965, 9 p.Article

Potential Benefits of Slow Titration of Paroxetine Treatment in an Elderly Population: Eight-Week Results From a Naturalistic SettingGIBIINO, Sara; MORI, Elisa; DE RONCHI, Diana et al.Journal of clinical psychopharmacology. 2013, Vol 33, Num 4, pp 565-569, issn 0271-0749, 5 p.Article

Combined Prolonged Exposure Therapy and Paroxetine for PTSD Related to the World Trade Center Attack: A Randomized Controlled TrialSCHNEIER, Franklin R; NERIA, Yuval; PAVLICOVA, Martina et al.The American journal of psychiatry. 2012, Vol 169, Num 1, pp 80-88, issn 0002-953X, 9 p.Article

Neurobehavioral Effects of Interferon-α in Patients with Hepatitis-C: Symptom Dimensions and Responsiveness to ParoxetineMCNUTT, Marcia D; SHULING LIU; MANATUNGA, Amita et al.Neuropsychopharmacology (New York, NY). 2012, Vol 37, Num 6, pp 1444-1454, issn 0893-133X, 11 p.Article

The association between sunshine duration and paroxetine response time in patients with major depressive disorderTOMITA, Tetsu; YASUI-FURUKORI, Norio; NAKAGAMI, Taku et al.Journal of affective disorders. 2012, Vol 136, Num 3, pp 1067-1071, issn 0165-0327, 5 p.Article

Detecting Drug Interactions From Adverse-Event Reports: Interaction Between Paroxetine and Pravastatin Increases Blood Glucose LevelsTATONETTI, N. P; DENNY, J. C; MURPHY, S. N et al.Clinical pharmacology and therapeutics. 2011, Vol 90, Num 1, pp 133-142, issn 0009-9236, 10 p.Article

Erythema multiforme photoinduced by paroxetine and herpes simplex virusRODRIGUEZ-PAZOS, Laura; GOMEZ-BERNAL, Silvia; MONTERO, Iria et al.Photodermatology photoimmunology & photomedicine. 2011, Vol 27, Num 4, pp 219-221, issn 0905-4383, 3 p.Article

Differences between mice strains in response to paroxetine in the forced swimming test: Involvement of serotonergic or noradrenergic systemsSUGIMOTO, Yumi; YAMAMOTO, Masami; TAGAWA, Noriko et al.European journal of pharmacology. 2011, Vol 672, Num 1-3, pp 121-125, issn 0014-2999, 5 p.Article

Functional magnetic resonance imaging study on the effects of acute single administration of paroxetine on motivation-related brain activityMARUTANI, Toshiyuki; YAHATA, Noriaki; IKEDA, Yumiko et al.Psychiatry and clinical neurosciences (Carlton. Print). 2011, Vol 65, Num 2, pp 191-198, issn 1323-1316, 8 p.Article

Meta-Regression Analysis of Paroxetine Clinical Trial Data: Does Reporting Scale Matter?KLEMP, Marianne; TVETE, Ingunn F; GASEMYR, Jørund et al.Journal of clinical psychopharmacology. 2011, Vol 31, Num 2, pp 201-206, issn 0271-0749, 6 p.Article

Neural response to eye contact and paroxetine treatment in generalized social anxiety disorderSCHNEIER, Franklin R; POMPLUN, Marc; SY, Melissa et al.Psychiatry research. Neuroimaging. 2011, Vol 194, Num 3, pp 271-278, issn 0925-4927, 8 p.Article

Elevated BDNF protein level in cortex but not in hippocampus of MDMA-treated Dark Agouti rats: A potential link to the long-term recovery of serotonergic axonsADORI, Csaba; ANDO, Rómeó D; FERRINGTON, Linda et al.Neuroscience letters. 2010, Vol 478, Num 2, pp 56-60, issn 0304-3940, 5 p.Article

Identification of Cytochrome P450 Isoforms Involved in the Metabolism of Paroxetine and Estimation of Their Importance for Human Paroxetine Metabolism Using a Population-Based SimulatorJORNIL, Jakob; JENSEN, Klaus Gjervig; LARSEN, Frank et al.Drug metabolism and disposition. 2010, Vol 38, Num 3, pp 376-385, issn 0090-9556, 10 p.Article

Serotonin Syndrome After a Massive Overdose of Controlled-Release ParoxetineMUZYK, Andrew J; JAKEL, Rebekah J; PREUD'HOMME, Xavier et al.Psychosomatics (Washington, DC). 2010, Vol 51, Num 5, pp 437-442, issn 0033-3182, 6 p.Article

Comparisons of the Efficacy and Tolerability of Extended-Release Venlafaxine, Mirtazapine, and Paroxetine in Treatment-Resistant Depression: A Double-Blind, Randomized Pilot Study in a Chinese PopulationYIRU FANG; CHENGMEI YUAN; KEMING GAO et al.Journal of clinical psychopharmacology. 2010, Vol 30, Num 4, pp 357-364, issn 0271-0749, 8 p.Article

Effects of paroxetine on emotional functioning and treatment awareness: a 4-week randomized placebo-controlled study in healthy cliniciansBESNIER, Nathalie; CASSE-PERROT, Catherine; JOUVE, Elisabeth et al.Psychopharmacologia. 2010, Vol 207, Num 4, pp 619-629, issn 0033-3158, 11 p.Article